Just in the previous decade, researchers have understood the huge role that the microbes living inside and on us play in our health. The human microbiome, and especially the gut microbiome, has actually been connected to several persistent diseases, including diabetes. An out of balance microbiome composition has been found in clients with diabetes, who tend to have a less varied gut microbiome as compared to healthy individuals. Search.
Some companies are establishing diabetes treatments targeting the microbiome. The French Valviotis is currently performing preclinical screening of a drug focused on increasing the microbiome diversity as a treatment for type 2 diabetes. Although promising, the microbiome field is really young and its intricacy makes it challenging to develop causation after finding connection.
That world might not be up until now away, as lots of companies are developing non-invasive techniques to substitute finger pricking. Search. Stability Applications has developed a device called GlucoTrack that can determine glucose utilizing electromagnetic waves and is already readily available in Europe. Comparable technologies are appearing, with GlucoSense in London utilizing laser light to measure sugar levels and MediWise making usage of radio waves.
The GlucoWise sensing unit prototypePatches are also ending up being a popular type of determining blood glucose without needles, such as FreeStyle Libre, an inch-wide spot that can be used for up to 2 weeks. At the University of Bath, scientists are developing a graphene spot that might provide higher precision by measuring sugar levels individually in numerous hair roots – Search.
Meanwhile, Senseonic and Roche are dealing with a device that is implanted under the skin. Search. Still, non-invasive choices to measure blood sugar frequently deal with concerns regarding precision. The well-known glucose-measuring contact lens that Google revealed in 2014 was dismissed as “technically infeasible” and even more developments will be needed to reach the degree of precision of finger-pricking techniques.
Researchers are already hypothesizing about microchips that can identify diabetes type 1 prior to the signs appear or nanorobots taking a trip in the blood stream while they determine glucose and provide insulin – Search.”There’s little fiction left in this. I highly think that microrobotics will come and will become part of our drug delivery within the next ten years,” said Tomas Landh, Director of Method and Innovation Sourcing at Novo Nordisk, at the 2013 Medicon Valley Alliance Annual MeetingWhatever the future brings, it will unquestionably make a huge difference in the lives of millions of people worldwide.